JYNT Fundamental Analysis - JOINT CORP/THE

Fundamental Rating

JYNT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. While JYNT has a great health rating, there are worries on its profitability. JYNT has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

JYNT had negative earnings in the past year.

In the past year JYNT had a positive cash flow from operations.

In multiple years JYNT reported negative net income over the last 5 years.

In the past 5 years JYNT always reported a positive cash flow from operatings.

1.2 Ratios

Looking at the Return On Assets, with a value of -11.29%, JYNT is doing worse than 79.61% of the companies in the same industry.

The Return On Equity of JYNT (-43.45%) is worse than 71.84% of its industry peers.

		Industry Rank	Sector Rank
ROA	-11.29%
ROE	-43.45%
ROIC	N/A

ROA(3y)-7.08%

ROA(5y)1.51%

ROE(3y)-28.18%

ROE(5y)0.6%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 83.94%, JYNT belongs to the top of the industry, outperforming 96.12% of the companies in the same industry.

JYNT's Gross Margin has declined in the last couple of years.

JYNT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	83.94%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.87%

GM growth 5Y-2.53%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.

JYNT has about the same amout of shares outstanding than it did 1 year ago.

JYNT has more shares outstanding than it did 5 years ago.

There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

JYNT has an Altman-Z score of 3.15. This indicates that JYNT is financially healthy and has little risk of bankruptcy at the moment.

JYNT has a Altman-Z score of 3.15. This is in the better half of the industry: JYNT outperforms 67.96% of its industry peers.

There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	3.15

ROIC/WACCN/A

WACC9.05%

2.3 Liquidity

A Current Ratio of 1.58 indicates that JYNT should not have too much problems paying its short term obligations.

JYNT has a Current ratio of 1.58. This is comparable to the rest of the industry: JYNT outperforms 54.37% of its industry peers.

JYNT has a Quick Ratio of 1.58. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.

JYNT has a Quick ratio of 1.58. This is comparable to the rest of the industry: JYNT outperforms 57.28% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.58
Quick Ratio	1.58

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

JYNT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 58.67%, which is quite impressive.

JYNT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.24%.

JYNT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.36% yearly.

EPS 1Y (TTM)58.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-150%

Revenue 1Y (TTM)5.24%

Revenue growth 3Y-13.43%

Revenue growth 5Y1.36%

Sales Q2Q%-56%

3.2 Future

The Earnings Per Share is expected to grow by 73.24% on average over the next years. This is a very strong growth

Based on estimates for the next years, JYNT will show a very negative growth in Revenue. The Revenue will decrease by -20.41% on average per year.

EPS Next Y115.45%

EPS Next 2Y107.52%

EPS Next 3Y73.24%

EPS Next 5YN/A

Revenue Next Year-53.26%

Revenue Next 2Y-27.92%

Revenue Next 3Y-20.41%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 22.31, which indicates a rather expensive current valuation of JYNT.

Compared to the rest of the industry, the Price/Forward Earnings ratio of JYNT is on the same level as its industry peers.

When comparing the Price/Forward Earnings ratio of JYNT to the average of the S&P500 Index (35.33), we can say JYNT is valued slightly cheaper.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	22.31

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of JYNT is on the same level as its industry peers.

		Industry Rank	Sector Rank
P/FCF	96.76
EV/EBITDA	N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

A more expensive valuation may be justified as JYNT's earnings are expected to grow with 73.24% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y107.52%

EPS Next 3Y73.24%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for JYNT!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

JOINT CORP/THE

NASDAQ:JYNT (7/15/2025, 8:00:02 PM)

After market: 11.32 0 (0%)

11.32

-0.13 (-1.14%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)05-08 2025-05-08/amc

Earnings (Next)08-07 2025-08-07/amc

Inst Owners74.67%

Inst Owner Change0%

Ins Owners1.67%

Ins Owner Change5.61%

Market Cap173.20M

Analysts78.18

Price Target15.68 (38.52%)

Short Float %3.84%

Short Ratio7.95

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-26.34%

Min Revenue beat(2)-51.14%

Max Revenue beat(2)-1.53%

Revenue beat(4)2

Avg Revenue beat(4)-11.86%

Min Revenue beat(4)-51.14%

Max Revenue beat(4)4.33%

Revenue beat(8)3

Avg Revenue beat(8)-6.4%

Revenue beat(12)5

Avg Revenue beat(12)-4.14%

Revenue beat(16)7

Avg Revenue beat(16)-2.94%

PT rev (1m)0%

PT rev (3m)-6.11%

EPS NQ rev (1m)-40%

EPS NQ rev (3m)0%

EPS NY rev (1m)-71.02%

EPS NY rev (3m)-90.61%

Revenue NQ rev (1m)-0.01%

Revenue NQ rev (3m)-1.67%

Revenue NY rev (1m)-0.22%

Revenue NY rev (3m)-1.26%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	22.31
P/S	1.38
P/FCF	96.76
P/OCF	59.52
P/B	8.66
P/tB	8.66
EV/EBITDA	N/A

EPS(TTM)-0.31

EYN/A

EPS(NY)0.51

Fwd EY4.48%

FCF(TTM)0.12

FCFY1.03%

OCF(TTM)0.19

OCFY1.68%

SpS8.19

BVpS1.31

TBVpS1.31

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-11.29%
ROE	-43.45%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	83.94%
FCFM	1.43%

ROA(3y)-7.08%

ROA(5y)1.51%

ROE(3y)-28.18%

ROE(5y)0.6%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.87%

GM growth 5Y-2.53%

F-Score6

Asset Turnover1.63

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Debt/EBITDA	N/A
Cap/Depr	30.19%
Cap/Sales	0.89%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.58
Quick Ratio	1.58
Altman-Z	3.15

F-Score6

WACC9.05%

ROIC/WACCN/A

Cap/Depr(3y)57.4%

Cap/Depr(5y)93.26%

Cap/Sales(3y)6.25%

Cap/Sales(5y)6.58%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)58.67%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-150%

EPS Next Y115.45%

EPS Next 2Y107.52%

EPS Next 3Y73.24%

EPS Next 5YN/A

Revenue 1Y (TTM)5.24%

Revenue growth 3Y-13.43%

Revenue growth 5Y1.36%

Sales Q2Q%-56%

Revenue Next Year-53.26%

Revenue Next 2Y-27.92%

Revenue Next 3Y-20.41%

Revenue Next 5YN/A

EBIT growth 1Y-644.69%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year300.43%

EBIT Next 3Y74.18%

EBIT Next 5YN/A

FCF growth 1Y-78.22%

FCF growth 3Y6.31%

FCF growth 5Y15.29%

OCF growth 1Y-79.26%

OCF growth 3Y-12.04%

OCF growth 5Y4.61%

JOINT CORP/THE (JYNT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens